High Tide Inc. (HITI)

USD 2.4

(0.0%)

EBITDA Summary of High Tide Inc.

  • High Tide Inc.'s latest annual EBITDA in 2023 was -4.2 Million CAD , up 198.78% from previous year.
  • High Tide Inc.'s latest quarterly EBITDA in 2024 Q3 was 10.17 Million CAD , up 14.14% from previous quarter.
  • High Tide Inc. reported an annual EBITDA of -33.64 Million CAD in 2022, up 108.5% from previous year.
  • High Tide Inc. reported an annual EBITDA of 4.82 Million CAD in 2021, down -21.21% from previous year.
  • High Tide Inc. reported a quarterly EBITDA of 10.17 Million CAD for 2024 Q3, up 14.14% from previous quarter.
  • High Tide Inc. reported a quarterly EBITDA of 10.79 Million CAD for 2024 Q1, up 133.36% from previous quarter.

Annual EBITDA Chart of High Tide Inc. (2023 - 2016)

Historical Annual EBITDA of High Tide Inc. (2023 - 2016)

Year EBITDA EBITDA Growth
2023 -4.2 Million CAD 198.78%
2022 -33.64 Million CAD 108.5%
2021 4.82 Million CAD -21.21%
2020 6.12 Million CAD 131.02%
2019 -19.73 Million CAD -396.95%
2018 -3.97 Million CAD -452.65%
2017 963.32 Thousand CAD -33.6%
2016 1.69 Million CAD 0.0%

Peer EBITDA Comparison of High Tide Inc.

Name EBITDA EBITDA Difference
CannBioRx Life Sciences Corp. -22.13 Million USD 81.025%
China Jo-Jo Drugstores, Inc. 1.22 Million USD 442.342%
Harrow Health, Inc. 8.625% Senior Notes due 2026 9.72 Million USD 143.197%
Harrow Health, Inc. 11.875% Senior Notes due 2027 9.72 Million USD 143.197%
Leafly Holdings, Inc. -5.73 Million USD 26.753%
LifeMD, Inc. -8.21 Million USD 48.869%
LifeMD, Inc. -8.21 Million USD 48.869%
TRxADE HEALTH, Inc. -13.72 Million USD 69.389%
PetMed Express, Inc. -394 Thousand USD -965.99%
Walgreens Boots Alliance, Inc. -11.27 Billion USD 99.963%